SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dhanuka Agritech surges on launching new product ‘NEMATAXE’

05 Jun 2023 Evaluate

Dhanuka Agritech is currently trading at Rs. 719.75, up by 7.55 points or 1.06% from its previous closing of Rs. 712.20 on the BSE.

The scrip opened at Rs. 715.65 and has touched a high and low of Rs. 721.00 and Rs. 712.10 respectively. So far 574 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 748.90 on 05-Sep-2022 and a 52 week low of Rs. 603.05 on 03-Apr-2023.

Last one week high and low of the scrip stood at Rs. 725.60 and Rs. 703.80 respectively. The current market cap of the company is Rs. 3258.39 crore.

The promoters holding in the company stood at 70.18%, while Institutions and Non-Institutions held 20.69% and 9.13% respectively.

Dhanuka Agritech has launched new product 'NEMATAXE' under biological insecticide category. The product is beneficial to 'Nematophagous Fungus: paecilomyces lilacinus'. The newly launched product caters to domestic market. 

Earlier, the company had set up a new research and development (R&D) centre at Palwal in Haryana with an investment of Rs 10 crore.

Dhanuka Agritech is one of India’s leading agro-chemical Company. It has solutions for all major crops grown in the country including cotton, paddy, wheat, sugarcane, pulses, fruits & vegetables, plantation crops and others.

Dhanuka Agritech Share Price

1033.35 -36.95 (-3.45%)
24-Apr-2026 13:17 View Price Chart
Peers
Company Name CMP
UPL 630.00
PI Industries 3104.10
Bayer CropScience 4677.50
Sharda Cropchem 1113.85
Sumitomo Chemical 439.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×